Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the first quarter report for 2024 on May 7, 10:00 CEST.

DENTSPLY SIRONA Inc. announced its financial results for the first quarter of 2024.

BD, a leading global medical technology company, announced results for its second quarter of fiscal 2024, which ended March 31, 2024.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced plans to participate in the upcoming Bank of America Healthcare Conference.

GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024.